Bordini, Jessica
Lenzi, Chiara
Frenquelli, Michela
Morabito, Alessia http://orcid.org/0009-0009-2313-6748
Pseftogas, Athanasios
Belloni, Daniela
Mansouri, Larry
Tsiolas, George
Perotta, Eleonora
Ranghetti, Pamela
Gandini, Francesca http://orcid.org/0000-0001-8930-8295
Genova, Francesca http://orcid.org/0000-0002-7470-6386
Hägerstrand, Daniel http://orcid.org/0000-0001-7270-0776
Gavriilidis, Georgios
Keisaris, Sofoklis
Pechlivanis, Nikolaos
Davi, Frederic
Kay, Neil E. http://orcid.org/0000-0002-5951-5055
Langerak, Anton W. http://orcid.org/0000-0002-2078-3220
Pospisilova, Sarka
Scarfò, Lydia http://orcid.org/0000-0002-0844-0989
Makris, Antonios
Psomopoulos, Fotis E. http://orcid.org/0000-0002-0222-4273
Stamatopoulos, Kostas
Rosenquist, Richard http://orcid.org/0000-0002-0211-8788
Campanella, Alessandro http://orcid.org/0000-0002-3463-1199
Ghia, Paolo http://orcid.org/0000-0003-3750-7342
Article History
Received: 4 July 2023
Revised: 11 March 2024
Accepted: 20 March 2024
First Online: 4 April 2024
Competing interests
: PG: honoraria/advisory board: AbbVie, Acerta/AstraZeneca, Adaptive, ArQule/MSD, BeiGene, CelGene/Juno, Gilead, Janssen, Loxo/Lilly, Sunesis; research funding: AbbVie, Gilead, Janssen, Novartis, Sunesis. RR: honoraria/advisory board: Abbvie, AstraZeneca, Janssen, Illumina and Roche. KS: honoraria/advisory board: AbbVie, Acerta/AstraZeneca, Gilead, Janssen; research funding: AbbVie, Gilead, Janssen.; NEK: Advisory Board for: AbbVie, Astra Zeneca, Beigene, Behring, Boehringer Ingelheim Pharmaceuticals, Inc., Dava Oncology, Janssen, Juno Therapeutics, Pharmacyclics. DSMC (Data Safety Monitoring Committee) for: Agios Pharm, AstraZeneca, BMS –Celgene, Dren Bio Janssen,. Research funding from: AbbVie, Acerta Pharma, Bristol Meyer Squib, Celgene, Genentech, Pharmacyclics, Sunesis, Vincerx.; LS: advisory board: AbbVie, AstraZeneca, Janssen.